YPHDF (Ypsomed Holding AG) YoY EBITDA Growth: 38.25% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

YPHDF Ypsomed Holding AG YPHDF
91 GF Score
Price $501.00
GF Value $520.43
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Ypsomed Holding AG YoY EBITDA Growth?

Ypsomed Holding AG YPHDF 91 YoY EBITDA Growth is 38.25% as of Mar. 2026. GuruFocus rates YPHDF with a GF Score™ of 91/100 and a GF Value™ of $520.43 (Fairly Valued). The stock has 6 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Ypsomed Holding AG's YoY EBITDA Growth for the quarter that ended in Mar. 2026 was 38.25%.

Ypsomed Holding AG's EBITDA per Share for the six months ended in Mar. 2026 was $13.07.

Ypsomed Holding AG YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Ypsomed Holding AG's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ypsomed Holding AG YoY EBITDA Growth Chart

Ypsomed Holding AG Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 49.95 35.78 20.50 18.84 92.43

Ypsomed Holding AG Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.55 6.87 34.62 158.47 38.25
YPHDF
91GF Score
Ypsomed Holding AG YPHDF
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ypsomed Holding AG YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Ypsomed Holding AG's YoY EBITDA Growth for the fiscal year that ended in Mar. 2026 is calculated as:

YoY EBITDA Growth (A: Mar. 2026 )
=(EBITDA per Share (A: Mar. 2026 )-EBITDA per Share (A: Mar. 2025 ))/ | EBITDA per Share (A: Mar. 2025 ) |
=(30.462-15.83)/ | 15.83 |
=92.43 %

Ypsomed Holding AG's YoY EBITDA Growth for the quarter that ended in Mar. 2026 is calculated as:

YoY EBITDA Growth (Q: Mar. 2026 )
=(EBITDA per Share (Q: Mar. 2026 )-EBITDA per Share (Q: Mar. 2025 )) / | EBITDA per Share (Q: Mar. 2025 )) |
=(13.074-9.457)/ | 9.457 |
=38.25 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 38.25% mean?
Ypsomed Holding AG (YPHDF) has a YoY EBITDA Growth of 38.25% as of Mar. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Ypsomed Holding AG and its competitors.
Is Ypsomed Holding AG's YoY EBITDA Growth too high?
Ypsomed Holding AG's current YoY EBITDA Growth is 38.25%. Overall, Ypsomed Holding AG has a GF Score™ of 91/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ypsomed Holding AG's YoY EBITDA Growth compare to ISRG and BDX?
Ypsomed Holding AG's YoY EBITDA Growth of 38.25% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Medical Devices & Instruments company?
A good YoY EBITDA Growth depends on the Medical Devices & Instruments industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Ypsomed Holding AG and its competitors. Ypsomed Holding AG's current YoY EBITDA Growth is 38.25%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ypsomed Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Ypsomed Holding AG (YPHDF) is currently considered Fairly Valued. The stock's GF Value™ is $520.43, compared to a current price of $501.00 — trading 3.7% below its estimated fair value. The current YoY EBITDA Growth is 38.25%. Ypsomed Holding AG's overall GF Score™ is 91/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Ypsomed Holding AG (YPHDF), the current YoY EBITDA Growth is 38.25% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ypsomed Holding AG (YPHDF) Overvalued in 2026?

Based on GuruFocus' analysis, Ypsomed Holding AG stock appears to be undervalued. The current stock price of $501.00 is trading 3.7% below its estimated GF Value™ of $520.43. GuruFocus considers Ypsomed Holding AG to be Fairly Valued.

Key valuation signals for YPHDF:

  • YoY EBITDA Growth: 38.25%
  • GF Value™: $520.43 vs. price of $501.00 (3.7% below fair value)
  • GF Score™: 91/100 with 6 warning signs

No single metric tells the full story. See the YPHDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ypsomed Holding AG Business Description

Address Brunnmattstrasse 6, Burgdorf, CHE, 3401
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a click-on function. The company operates under two reportable segments: Ypsomed Delivery Systems and Ypsomed Diabetes Care.
91GF Score

Get the complete analysis for YPHDF

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$501.00
Price
$520.43
GF Value